Bayer Articles
Bayer in licensing deal with Japanese firms for imaging agents
29 January 2007
Hungary issues list of non-pharmacy OTCs
29 January 2007
Stock Commentary - Europe - week to Jan 15, 2007
22 January 2007
Mangement board appointments at Bayer Schering Pharma
22 January 2007
Aerovance's Aerovant performs well in Phase IIa asthma trial
15 January 2007
Good Ph III data for Bayer/Onyx Nexavar
15 January 2007
Bayer Yakuhin names new president
8 January 2007
Court affirms $7M damages for Innogenetics from Abbott
8 January 2007
Stock Commentary - Europe - week to Jan 1, 2007
8 January 2007
Bayer Yakuhin files Fosrenol in Japan
22 December 2006
Bayer announces Trasylol label revisions
22 December 2006
Bayer donates $25M worth of antibiotics to MAP
22 December 2006
Squeeze out of minority Schering shareholders
11 December 2006
Nexavar fails in Ph III melanoma study
11 December 2006
Stock Commentary - Europe - week to Nov 27
4 December 2006
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Versant 2.0 HCV assay launched in Europe
27 November 2006
Betaferon OKed in Australia for earliest stages of MS
27 November 2006
Stock Commentary - Europe - week to Nov 13, 2006
20 November 2006
Stock Commentary - Europe - week to Nov 6, 2006
13 November 2006
Go-ahead for Schering AG integration with Bayer
13 November 2006
Levitra effective in ED in men with CV disease
13 November 2006
Stock Commentary - Europe - week to Oct 30, 2006
6 November 2006
25 new drugs get AIFA coverage in Italy
6 November 2006
Analysts view pharma revenue exposure in Japan
6 November 2006
Bayer buys China-based Topsun's OTC business for $136M
30 October 2006
German drug firms pressured by WHO
30 October 2006
Schering AG's Betaferon gets expanded US label
30 October 2006
Bayer and CAS extend collaboration
23 October 2006
Bayer appoints independent Trasylol investigator
23 October 2006
Stock Commentary - Europe - week to Oct 9, 2006
16 October 2006
FDA public advisory on Bayer
9 October 2006
FDA OKs new indiction for Schering AG's YAZ
9 October 2006
Trasylol endorsed by FDA in CABG surgery
2 October 2006
Fastest drug developers
25 September 2006
Tough challenges in China's OTC market
25 September 2006
84% of 40-plus Americans view aspirin a "wonder"
25 September 2006
Bayer/J&J and BI atrial fibrillation drugs "have blockbuster potential"
18 September 2006
Bayer's Avelox "as effective" as potent combo regimen for CA pneumonia
11 September 2006
GW's Sativex filed for MS spasticity in Europe
11 September 2006
Bayer's anticoagulant rivaroxaban shows promise in Ph II DVT studies
11 September 2006
Bayer HealthCare to invest $26M in China
11 September 2006
Schering AG contributions to Indonesia, Thailand reconstruction
11 September 2006
Bayer
4 September 2006
Stock Commentary - Europe - week to Aug 28, 2006
4 September 2006
Japan stock market week to Aug 28, 2006
4 September 2006
FDA petitioned for warnings on fluoroquinolones
4 September 2006
FDA approves generic version of Bayer's Cipro
4 September 2006
Stock Commentary - Europe - week to Aug 7, 2006
14 August 2006
Movianto signs deal with Bayer for Czech distribution
14 August 2006
Stock Commentary - Europe - week to Aug 7, 2006
7 August 2006
Industry bodies oppose annual revision of Japan
7 August 2006
KPMG puts value of $21.12B on Schering AG
7 August 2006
Takeover costs impact Schering AG's 1st-half 2006
31 July 2006
Merck KGaA's 2nd-qtr profit surges up 113%
31 July 2006
EC approves Bayer's Nexavar for RCC
31 July 2006
Bayer plans to out-license CuraGen drug candidate
31 July 2006
Takeover costs impact Schering's 1st-half 2006
26 July 2006
Schering AG enters AD diagnostics deal with Avid
24 July 2006
Bayer debuts free US patient trial of Kognate
24 July 2006
Bayer names Martin Dawkins as MD for UK and Ireland
17 July 2006
Stock Commentary - Europe - week to July 10, 2006
17 July 2006
Bayer completes Schering AG takeover
17 July 2006
Axaron/LION to form new CNS drugmaker
17 July 2006
Bayer buys US diabetes device firm
17 July 2006
EFPIA re-elects president and names new VPs
10 July 2006
Bayer buys more shares in Schering AG
10 July 2006
Stock Commentary - Europe - week to July 3, 2006
10 July 2006
J&J wins bidding war for Pfizer
3 July 2006
Part D effect on US drug prices: up or down?
3 July 2006
Way clear for Bayer bid for Schering AG
26 June 2006
Stock Commentary - Europe - week to June 12, 2006
19 June 2006
Pfizer licenses Bayer's DGAT-1 inhibitors
19 June 2006
Merck KGaA moves to scupper Schering/Bayer marriage?
19 June 2006
Merck KGaA confirms 5%+ stake in Schering AG
12 June 2006
Bayer extends Schering AG takeover period
5 June 2006
Shionogi's 2005 sales 196.4B yen, down 1.5%
29 May 2006
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
